Mercado mundial de terapia con plasma: tendencias de la industria y pronóstico hasta 2028

Análisis y perspectivas del mercado: mercado mundial de terapia con plasma

Se espera que el mercado de la terapia con plasma experimente un crecimiento del mercado a una tasa del 13,66% en el período de pronóstico de 2021 a 2028. El informe de investigación de mercado de Data Bridge sobre el mercado de la terapia con plasma proporciona análisis e información sobre los diversos factores que se espera que prevalezcan durante el período de pronóstico, al tiempo que proporciona sus impactos en el crecimiento del mercado. El aumento de la incidencia de lesiones deportivas está acelerando el crecimiento del mercado de la terapia con plasma.

Se sabe que la sangre está compuesta de glóbulos blancos (WBC), glóbulos rojos (RBC), plasma y plaquetas. En la terapia con plasma, la inmunidad de un individuo sano recuperado puede ser transportada al paciente con la ayuda del plasma, porque contiene una alta concentración de anticuerpos. La terapia con plasma se ha utilizado durante mucho tiempo, principalmente en odontología, dermatología y ortopedia. El tratamiento con plasma se utiliza generalmente en la curación de heridas, la alopecia androgénica y la restauración facial.

Los principales factores que se espera que impulsen el crecimiento del mercado de la terapia con plasma en el período de pronóstico son el aumento en el número de pacientes con alopecia androgénica en todo el mundo. Además, se prevé que el aumento en la utilización de plasma rico en plaquetas en las diversas áreas terapéuticas impulse aún más el crecimiento del mercado de la terapia con plasma. Además, se estima que el aumento en la incidencia de la artritis amortiguará el crecimiento del mercado de la terapia con plasma. Por otro lado, se prevé que la escasez de políticas de reembolso y los diferentes costos de la terapia con plasma impidan aún más el crecimiento del mercado de la terapia con plasma en el período de tiempo previsto.

Además, el aumento del número de pacientes que padecen trastornos ortopédicos y alopecia androgénica ofrecerá más oportunidades potenciales para el crecimiento del mercado de terapia de plasma en los próximos años. Sin embargo, la utilización limitada de PRP en los pacientes que padecen diabetes y enfermedades renales podría crear más desafíos para el crecimiento del mercado de terapia de plasma en el futuro cercano.

This plasma therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on plasma therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Plasma Therapy Market Scope and Market Size

The plasma therapy market is segmented on the basis of type, source, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of type, the plasma therapy market is segmented into pure PRP, leucocyte-rich PRP, pure platelet-rich fibrin, leukocyte-rich fibrin.
• On the basis of source, the plasma therapy market is segmented into autologous, allogenic.
• On the basis of application, the plasma therapy market is segmented into orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, others. Orthopedics is further sub segmented into arthritis, chronic tendinitis and bone repair and regeneration. Dermatology is further sub segmented into androgenic alopecia and plastic surgery.
• On the basis of end user, the plasma therapy market is segmented into hospitals and clinics, research institutions.

Plasma Therapy Market Country Level Analysis

The plasma therapy market is analysed and market size insights and trends are provided by country, type, source, application and end user as referenced above.      

The countries covered in the plasma therapy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the plasma therapy market due to the rise in the number of hospitals and clinics. Furthermore, the increase in the alertness levels amongst the blood donors and the existence of the advanced protein fractioning processes will further boost the growth of the plasma therapy market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the plasma therapy market due to the rise in the medical tourism and technological developments.

The country section of the plasma therapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The plasma therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for plasma therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the plasma therapy market. The data is available for historic period 2010-2019.

Competitive Landscape and Plasma Therapy Market Share Analysis

The plasma therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to plasma therapy market.

Los principales actores cubiertos en el informe del mercado de terapia de plasma son Arthrex, Inc., Bio Products Laboratory Ltd., Takeda Pharmaceutical Company Limited., Biotest AG., Cambryn Biologics, China Biologic Products Holdings, Inc., CSL Limited, DePuy Synthes, Grifols, SA, Kedrion SpA, Octapharma, Regen Lab SA, Stryker Corporation, Telecris Indústria e Comércio Ltda., Baxter, Sociedad Japonesa de la Cruz Roja, Sanquin Oy, LFB SA, TERUMO BCT, INC. y Chengdu Institute of Biology (CIB), entre otros actores nacionales y globales. Los datos de participación de mercado están disponibles para todo el mundo, América del Norte, Europa, Asia-Pacífico (APAC), Medio Oriente y África (MEA) y América del Sur por separado. Los analistas de DBMR comprenden las fortalezas competitivas y brindan un análisis competitivo para cada competidor por separado.

SKU-14345